Obstetrics and gynecology
-
Obstetrics and gynecology · Oct 2007
Multicenter StudyRisk of uterine rupture and adverse perinatal outcome at term after cesarean delivery.
Current information on the risk of uterine rupture after cesarean delivery has generally compared the risk after trial of labor to that occurring with an elective cesarean delivery without labor. Because antepartum counseling cannot account for whether a woman will develop an indication requiring a repeat cesarean delivery or whether labor will occur before scheduled cesarean delivery, the purpose of this analysis was to provide clinically useful information regarding the risks of uterine rupture and adverse perinatal outcome for women at term with a history of prior cesarean delivery. ⋯ At term, the risk of uterine rupture and adverse perinatal outcome for women with a singleton and prior cesarean delivery is low regardless of mode of delivery, occurring in 3 per 1,000 women. Maternal complications occurred in 3-8% of women within the five delivery groups.
-
Obstetrics and gynecology · Oct 2007
Comparative StudyObstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection.
To compare obstetric outcome and congenital abnormalities in pregnancies conceived after in vitro maturation (IVM), in vitro fertilization (IVF), and intracytoplasmic sperm injection (ICSI) with those in spontaneously conceived controls. ⋯ All ART pregnancies are associated with an increased risk of multiple pregnancy, cesarean delivery, and congenital abnormality. Compared with IVF and ICSI, IVM is not associated with any additional risk.
-
Obstetrics and gynecology · Oct 2007
ACOG Committee Opinion No. 383: Evaluation of stillbirths and neonatal deaths.
A complete evaluation of a stillbirth or neonatal death may explain the cause of death, direct further investigation of the family, and be particularly valuable in counseling parents about recurrence risks in future pregnancies. The results of the autopsy, placental examination, laboratory tests, and cytogenetic studies should be communicated to the involved clinicians and to the family of the deceased infant in a timely manner.